Exploring Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli in Food-Producing Animals and Animal-Derived Foods.

Autor: Ribeiro LF; Mário Palmério University Center (UniFucamp), Av. Brasil Oeste, s/n, Jardim Zenith, Monte Carmelo 38500-000, Minas Gerais State, Brazil., Nespolo NM; Federal University of São Carlos (UFSCar), Rod. Washington Luís, s/n-Monjolinho, São Carlos 13565-905, São Paulo State, Brazil., Rossi GAM; Department of Veterinary Medicine, University of Vila Velha (UVV), Vila Velha 29102-920, Espírito Santo State, Brazil., Fairbrother JM; Département de Pathologie et Microbiologie, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, QC J2S 2M2, Canada.
Jazyk: angličtina
Zdroj: Pathogens (Basel, Switzerland) [Pathogens] 2024 Apr 22; Vol. 13 (4). Date of Electronic Publication: 2024 Apr 22.
DOI: 10.3390/pathogens13040346
Abstrakt: Antimicrobials serve as crucial treatments in both veterinary and human medicine, aiding in the control and prevention of infectious diseases. However, their misuse or overuse has led to the emergence of antimicrobial resistance, posing a significant threat to public health. This review focuses on extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in animals and their associated food products, which contribute to the proliferation of antimicrobial-resistant strains. Recent research has highlighted the presence of ESBL-producing E. coli in animals and animal-derived foods, with some studies indicating genetic similarities between these isolates and those found in human infections. This underscores the urgent need to address antimicrobial resistance as a pressing public health issue. More comprehensive studies are required to understand the evolving landscape of ESBLs and to develop strategic public health policies grounded in the One Health approach, aiming to control and mitigate their prevalence effectively.
Databáze: MEDLINE